Towards Healthcare
APAC Insulin Syringes Market Reach USD 848.6 Mn by 2034

APAC Insulin Syringes Market 2025 Massive Growth Driven by AI, Elderly Care and Syringe Innovation

Projections indicate that, APAC insulin syringe industry is projected to rise from USD 462.8 million in 2024 to USD 848.6 million by 2034, reflecting a CAGR of 6.1% over the next decade. The market is growing due to rising prevalence of diabetes and increasing awareness about insulin therapy across the region. The availability of cost-effective alternatives in insulin syringes for drug deliver as compared to other solutions boosts the market’s growth in the region.

  • Insight Code: 5916
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The APAC insulin syringes market is projected to reach USD 848.6 million by 2034, growing at a CAGR of 6.1% from 2024 to 2034.

The market is growing due to the rising prevalence of diabetes and increasing adoption of insulin therapy.

1.0 mL syringes dominate due to their suitability for higher insulin doses.

0.3 mL syringes are the fastest growing as they cater to paediatric and low-dose patients.